---
title: Breast Cancer Screening Gets Personal | DOTmed
description: Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News.  cmAngio “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” and focuses on maximizing the mammogram for both breast cancer and heart disease detection.
image: https://blog.curemetrix.com/hubfs/cmAngio_computer_WEB_2.jpg
---

# [![UpdatedCureMetrix-LogoFinal_TM-1](https://blog.curemetrix.com/hs-fs/hubfs/UpdatedCureMetrix-LogoFinal_TM-1.png?width=634&name=UpdatedCureMetrix-LogoFinal_TM-1.png)](http://curemetrix.com/)

 

- [About](http://curemetrix.com/about/)
- [Results](http://curemetrix.com/biopsyreduction/)
- [Products](http://curemetrix.com/our-products/cm-assist/)
- [Our Partners](http://curemetrix.com/about/our-partners/)
- [Press](http://curemetrix.com/about/press/)
- [Publications](http://curemetrix.com/about/publications/)
- [Blog](https://blog.curemetrix.com)

- [About](http://curemetrix.com/about/) 
    - [Our Company](http://curemetrix.com/about/our-company/)
    - [Our Team](http://curemetrix.com/about/our-team/)
    - [Awards & Recognitions](http://curemetrix.com/about/awards-recognitions/)
    - [Press](http://curemetrix.com/about/press/)
    - [Publications](http://curemetrix.com/about/publications/)
    - [Careers](http://curemetrix.com/about/careers/)
    - [Contact](http://curemetrix.com/contact/)
- [Results](http://curemetrix.com/biopsyreduction/) 
    - The CureMetrix Approach
    - [Early Detection](http://curemetrix.com/biopsyreduction/case-studies/)
- [Products](http://curemetrix.com/our-products/cm-assist/)
- [Our Partners](http://curemetrix.com/about/our-partners/)
- [Press](http://curemetrix.com/about/press/)
- [Publications](http://curemetrix.com/about/publications/)
- [Blog](https://blog.curemetrix.com)

# CureMetrix AI Blog

# Breast Cancer Screening Gets Personal | DOTmed

Posted by [Navid Alipour, Chief Executive Officer](https://blog.curemetrix.com/author/navid-alipour-chief-executive-officer) on Jul 7, 2021 10:33:35 AM

![Navid Alipour, Chief Executive Officer](https://blog.curemetrix.com/hubfs/Headshots/Navid%20Alipour%20Headshot.jpg)

Focused on Women’s Health, CureMetrix AI-based cmAngio™ was highlighted in the July 2021 edition of DOTmed HealthCareBusiness News.  [cmAngio](https://curemetrix.com/cmangio/) “represents the potential to screen 40 million women a year for heart disease in the U.S. alone,” with AI that maximizes the mammogram for both breast cancer and heart disease detection.

![Dotmed 2](https://blog.curemetrix.com/hs-fs/hubfs/Dotmed%202.jpg?width=585&name=Dotmed%202.jpg)![Dotmed 1](https://blog.curemetrix.com/hs-fs/hubfs/Dotmed%201.jpg?width=551&name=Dotmed%201.jpg)

 

[Go to July 2021 edition of DOTmed](https://www.dotmed.com/viewer/072021/)

 Topics: [News](https://blog.curemetrix.com/tag/news), [AI](https://blog.curemetrix.com/tag/ai), [mammogram](https://blog.curemetrix.com/tag/mammogram), [cmTriage](https://blog.curemetrix.com/tag/cmtriage), [cmAssist](https://blog.curemetrix.com/tag/cmassist), [AI Mammogram](https://blog.curemetrix.com/tag/ai-mammogram), [CHD](https://blog.curemetrix.com/tag/chd), [heart disease](https://blog.curemetrix.com/tag/heart-disease), [cmangio](https://blog.curemetrix.com/tag/cmangio)

### **Shaping the Future of AI for Healthcare**

It's here, it's empowering , and it's moving fast. To keep you informed about advances in artificial intelligence for Radiology, sign up for our blog:  

- Industry News
- Insights
- Innovations

### Subscribe Here!

### Recent Posts

### Post by Tag

- [AI (28)](https://blog.curemetrix.com/tag/ai)
- [cmTriage (25)](https://blog.curemetrix.com/tag/cmtriage)
- [radiology (25)](https://blog.curemetrix.com/tag/radiology)
- [mammogram (24)](https://blog.curemetrix.com/tag/mammogram)
- [artificial intelligence (22)](https://blog.curemetrix.com/tag/artificial-intelligence)
- [mammography (22)](https://blog.curemetrix.com/tag/mammography)
- [breast cancer (21)](https://blog.curemetrix.com/tag/breast-cancer)
- [AI-CAD (20)](https://blog.curemetrix.com/tag/ai-cad)
- [CAD (19)](https://blog.curemetrix.com/tag/cad)
- [Machine Learning (19)](https://blog.curemetrix.com/tag/machine-learning)
- [screening (19)](https://blog.curemetrix.com/tag/screening)
- [breast cancer awareness (16)](https://blog.curemetrix.com/tag/breast-cancer-awareness)
- [AI Mammogram (14)](https://blog.curemetrix.com/tag/ai-mammogram)
- [Breast imaging (10)](https://blog.curemetrix.com/tag/breast-imaging)
- [Dense Breast (10)](https://blog.curemetrix.com/tag/dense-breast)
- [FFPI (10)](https://blog.curemetrix.com/tag/ffpi)
- [cmAssist (10)](https://blog.curemetrix.com/tag/cmassist)
- [News (9)](https://blog.curemetrix.com/tag/news)
- [BI-RADS Atlas 5th Edition (8)](https://blog.curemetrix.com/tag/bi-rads-atlas-5th-edition)
- [BRCA (8)](https://blog.curemetrix.com/tag/brca)
- [Deep Learning (7)](https://blog.curemetrix.com/tag/deep-learning)
- [heart disease (7)](https://blog.curemetrix.com/tag/heart-disease)
- [CHD (6)](https://blog.curemetrix.com/tag/chd)
- [artifical intelligence (6)](https://blog.curemetrix.com/tag/artifical-intelligence)
- [Cancer Detection (5)](https://blog.curemetrix.com/tag/cancer-detection)
- [ECR (5)](https://blog.curemetrix.com/tag/ecr)
- [NCBC (5)](https://blog.curemetrix.com/tag/ncbc)
- [SBI (5)](https://blog.curemetrix.com/tag/sbi)
- [black history month (5)](https://blog.curemetrix.com/tag/black-history-month)
- [breast density (5)](https://blog.curemetrix.com/tag/breast-density)
- [cmdensity (5)](https://blog.curemetrix.com/tag/cmdensity)
- [African American Women (3)](https://blog.curemetrix.com/tag/african-american-women)
- [Ashkenazi Jewish (3)](https://blog.curemetrix.com/tag/ashkenazi-jewish)
- [Asian Women (3)](https://blog.curemetrix.com/tag/asian-women)
- [Brazilian women (3)](https://blog.curemetrix.com/tag/brazilian-women)
- [Ethnic disparities (3)](https://blog.curemetrix.com/tag/ethnic-disparities)
- [Athena (2)](https://blog.curemetrix.com/tag/athena)
- [AuntMinnie (2)](https://blog.curemetrix.com/tag/auntminnie)
- [Case Studies (2)](https://blog.curemetrix.com/tag/case-studies)
- [RSNA (2)](https://blog.curemetrix.com/tag/rsna)
- [cmangio (2)](https://blog.curemetrix.com/tag/cmangio)
- [covid19 (2)](https://blog.curemetrix.com/tag/covid19)
- [google (2)](https://blog.curemetrix.com/tag/google)
- [innovation (2)](https://blog.curemetrix.com/tag/innovation)
- [Best Radiology Vendor (1)](https://blog.curemetrix.com/tag/best-radiology-vendor)
- [Communication (1)](https://blog.curemetrix.com/tag/communication)
- [Insider (1)](https://blog.curemetrix.com/tag/insider)
- [Partnering (1)](https://blog.curemetrix.com/tag/partnering)
- [radiology conferences (1)](https://blog.curemetrix.com/tag/radiology-conferences)
- [second opinion (1)](https://blog.curemetrix.com/tag/second-opinion)
- [siim (1)](https://blog.curemetrix.com/tag/siim)

See all

© 2022, CureMetrix, Inc. All rights reserved.   
[Terms of Use](http://curemetrix.com/terms-of-use/) | [Privacy Policy](http://curemetrix.com/privacy-policy/) | [Disclaimer](http://curemetrix.com/about/disclaimers/)

- [Home](http://curemetrix.com/)
- [About](http://curemetrix.com/about/)
- [Careers](http://curemetrix.com/about/careers/)
- [Contact](http://curemetrix.com/contact/)